Vimpat 50 mg

Vimpat 50 mg is a medicine authorised by Swissmedic under authorisation number 59002. The authorisation holder is UCB-Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 August 2009 and the authorisation is valid without a time limit. ATC code N03AX18 places the medicine in the group Antiepileptics.

  • Dispensing category B
  • Authorisation number 59002
  • ATC N03AX18
  • Synthetic medicines
Authorisation data
Authorisation number59002
NameVimpat 50 mg
Full nameVimpat 50 mg, comprimés pelliculés
Authorisation holderUCB-Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN03AX18
First authorisation28 August 2009
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Vimpat 50 mg, comprimés pelliculésB28 August 2009
2Vimpat 100 mg, comprimés pelliculésB28 August 2009
3Vimpat 150 mg, comprimés pelliculésB28 August 2009
4Vimpat 200 mg, comprimés pelliculésB28 August 2009

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
114Tablette(n)N03AX1801.07.1.B
314Tablette(n)N03AX1801.07.1.B
4168Tablette(n)N03AX1801.07.1.B
1356Tablette(n)N03AX1801.07.1.B
514Tablette(n)N03AX1801.07.1.B
6168Tablette(n)N03AX1801.07.1.B
1456Tablette(n)N03AX1801.07.1.B
714Tablette(n)N03AX1801.07.1.B
8168Tablette(n)N03AX1801.07.1.B
1556Tablette(n)N03AX1801.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Vimpat 50 mg authorised in Switzerland?

Yes. Vimpat 50 mg is authorised by Swissmedic under authorisation number 59002, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Vimpat 50 mg have?

Vimpat 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Vimpat 50 mg?

The authorisation holder is UCB-Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com